BioStem Technologies annual net debt
2021
2022
2023
2024
2025
BioStem Technologies Net Debt Growth & History (BSEM)
BioStem Technologies's net debt was −$29.2M for fiscal 2025.
View full BioStem Technologies company overviewBioStem Technologies annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$29.2M | −$10.8M | — |
| 2024 | 2024-12-31 | −$18.4M | −$22.9M | — |
| 2023 | 2023-12-31 | $4.5M | $167,395 | +3.88% |
| 2022 | 2022-12-31 | $4.3M | −$173,956 | −3.87% |
| 2021 | 2021-12-31 | $4.5M | — | — |
BioStem Technologies quarterly net debt
Q4.24
Q3.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$6.7M | — | — |
| Q4 2025 | 2025-12-31 | −$29.2M | −$10.8M | — |
| Q3 2025 | 2025-09-30 | −$23.8M | — | — |
| Q4 2024 | 2024-12-31 | −$18.4M | — | — |
BioStem Technologies net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, BioStem Technologies's net debt decreased from $4.5M to −$29.2M, a change of −$33.7M. The latest reported quarter, Q2 2026, shows −$6.7M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioStem Technologies source filings ↗